Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123033794 | 12303379 | 4 | F | 2009 | 20160603 | 20160426 | 20160830 | PER | US-JNJFOC-20160327416 | JANSSEN | 0.00 | C | M | Y | 0.00000 | 20160830 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123033794 | 12303379 | 1 | PS | RISPERDAL | RISPERIDONE | 1 | Oral | U | U | 20272 | .5 | MG | TABLETS | ||||||
| 123033794 | 12303379 | 2 | SS | RISPERIDONE. | RISPERIDONE | 1 | Oral | U | 0 | UNSPECIFIED | |||||||||
| 123033794 | 12303379 | 3 | SS | RISPERIDONE. | RISPERIDONE | 1 | Oral | 0.5 MG - 1 MG | U | 0 | UNSPECIFIED | ||||||||
| 123033794 | 12303379 | 4 | SS | RISPERIDONE. | RISPERIDONE | 1 | Oral | U | 20272 | .5 | MG | UNSPECIFIED | |||||||
| 123033794 | 12303379 | 5 | SS | RISPERDAL M-TAB | RISPERIDONE | 1 | Oral | U | U | 21444 | TABLETS | ||||||||
| 123033794 | 12303379 | 6 | SS | RISPERIDONE SANDOZ | RISPERIDONE | 1 | Oral | U | 0 | TABLETS | |||||||||
| 123033794 | 12303379 | 7 | SS | RISPERIDONE. | RISPERIDONE | 1 | Oral | U | 0 | TABLETS | |||||||||
| 123033794 | 12303379 | 8 | C | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | Unknown | 0 | 20 | MG | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123033794 | 12303379 | 1 | Autism |
| 123033794 | 12303379 | 2 | Autism |
| 123033794 | 12303379 | 3 | Autism |
| 123033794 | 12303379 | 4 | Autism |
| 123033794 | 12303379 | 5 | Product used for unknown indication |
| 123033794 | 12303379 | 6 | Product used for unknown indication |
| 123033794 | 12303379 | 7 | Product used for unknown indication |
| 123033794 | 12303379 | 8 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123033794 | 12303379 | Emotional disorder | |
| 123033794 | 12303379 | Gynaecomastia | |
| 123033794 | 12303379 | Obesity |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123033794 | 12303379 | 1 | 2007 | 2008 | 0 | |
| 123033794 | 12303379 | 2 | 2008 | 2013 | 0 | |
| 123033794 | 12303379 | 3 | 2011 | 2013 | 0 | |
| 123033794 | 12303379 | 4 | 2009 | 2010 | 0 | |
| 123033794 | 12303379 | 8 | 2008 | 0 |